# INITIAL FUNDING, RFP #N02-CM-37002-05, DTP-13-015,   02/01/2013 - 01/31/2014, SHE

> **NIH NIH N02** · MIDWEST RESEARCH INSTITUTE · 2024 · $7,163

## Abstract

The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working to generate a seamless pipeline of biomarkers and therapeutics that runs the gamut from initial efforts in drug discovery through late-stage clinical trials. New cancer imaging techniques play a critical role in support of this pipeline as advances in image-guided diagnosis and image-guided therapies continue to emerge.

## Key facts

- **NIH application ID:** 11070258
- **Project number:** 261201300007C-P00019-9999-1
- **Recipient organization:** MIDWEST RESEARCH INSTITUTE
- **Principal Investigator:** JONATHAN WHITE, PHD
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $7,163
- **Award type:** —
- **Project period:** 2013-02-01 → 2018-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11070258

## Citation

> US National Institutes of Health, RePORTER application 11070258, INITIAL FUNDING, RFP #N02-CM-37002-05, DTP-13-015,   02/01/2013 - 01/31/2014, SHE (261201300007C-P00019-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11070258. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*